Literature DB >> 16300890

Calcium oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation.

Jane M Johnston1, Paul Burnett, Andrew P Thomas, Nikolaos Tezapsidis.   

Abstract

Stimulation of type-1 astrocytes, by a number of agonists, has been shown to increase cytosolic Ca2+ concentrations in an oscillatory manner. However, it is unknown how these are driven or altered by aging, injury or disease. Therefore, we characterized the signaling properties of rat type-1 astrocytes in monolayer cultures. Ca2+ responses were recorded in astrocytes stimulated with ATP or glutamate. Oscillations were evident in cultures at 3 days in vitro (DIV 3) with a peak percentage (26%) of cells responding by DIV 7. The presence or absence of serum in the culture medium did not influence this percentage. Likewise, long-term culture (DIV 30+) did not increase the oscillating cell numbers. ATP was found to have a more potent effective dose (50 microM) than glutamate (10 mM). Membrane potential was recorded with fluorescent voltage-sensitive dye (membrane potential dye for FLIPR) and was similar regardless of the culture age and intracellular Ca2+ response. This suggests that mechanisms associated with the intracellular release of Ca2+ from endogenous Ca2+ stores, rather than ion fluxes across the plasma membrane, may contribute to the oscillations in the astrocytes. In order to identify a possible pathological significance of this response, we transfected astrocytes with wild-type presenilin (PS1) as well as PS1 harboring a mutation linked to familial Alzheimer's disease (FAD). PS mutation expressing astrocytes oscillated at lower ATP and glutamate concentrations when compared to wild-type PS1 expressing astrocytes. This indicates that PS1 mutation may introduce aberrations in the intracellular Ca2+ mobilization in astrocytes contributing to the accelerated pathogenesis in FAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300890     DOI: 10.1016/j.neulet.2005.10.088

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Expression of familial Alzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environment.

Authors:  Matjaž Stenovec; Saša Trkov; Eva Lasič; Slavica Terzieva; Marko Kreft; José Julio Rodríguez Arellano; Vladimir Parpura; Alexei Verkhratsky; Robert Zorec
Journal:  Glia       Date:  2015-10-14       Impact factor: 7.452

2.  Isn't functional neuroimaging all about Ca2+ signaling in astrocytes?

Authors:  Mauro DiNuzzo
Journal:  J Neurophysiol       Date:  2014-11-05       Impact factor: 2.714

3.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

4.  Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.

Authors:  King-Ho Cheung; Diana Shineman; Marioly Müller; César Cárdenas; Lijuan Mei; Jun Yang; Taisuke Tomita; Takeshi Iwatsubo; Virginia M-Y Lee; J Kevin Foskett
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

Review 5.  Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Authors:  Hong Lian; Hui Zheng
Journal:  J Neurochem       Date:  2015-11-30       Impact factor: 5.372

Review 6.  Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.

Authors:  Ju Gao; Luwen Wang; Jingyi Liu; Fei Xie; Bo Su; Xinglong Wang
Journal:  Antioxidants (Basel)       Date:  2017-04-05

7.  Amyloid β-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes.

Authors:  Siu-Kei Chow; Diana Yu; Christopher L Macdonald; Marius Buibas; Gabriel A Silva
Journal:  ASN Neuro       Date:  2010-01-25       Impact factor: 4.146

Review 8.  Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders.

Authors:  Yazan S Batarseh; Quoc-Viet Duong; Youssef M Mousa; Sweilem B Al Rihani; Khaled Elfakhri; Amal Kaddoumi
Journal:  Int J Mol Sci       Date:  2016-03-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.